4//SEC Filing
Olivo Alicia C 4
Accession 0001628280-26-002198
CIK 0001077183other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:22 PM ET
Size
28.7 KB
Accession
0001628280-26-002198
Insider Transaction Report
Form 4
Olivo Alicia C
EVP, GC & Business Development
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-13+59,382→ 90,465 total - Tax Payment
Common Stock
[F2]2026-01-13−15,145→ 75,320 total
Holdings
- 1,046
Stock Option (Right to Buy)
[F3]Exercise: $19.12Exp: 2026-09-30→ Common Stock (1,046 underlying) - 1,024
Stock Option (Right to Buy)
[F4]Exercise: $27.34Exp: 2027-05-01→ Common Stock (1,024 underlying) - 516
Stock Option (Right to Buy)
[F5]Exercise: $48.99Exp: 2028-05-01→ Common Stock (516 underlying) - 1,117
Stock Option (Right to Buy)
[F6]Exercise: $46.10Exp: 2028-08-01→ Common Stock (1,117 underlying) - 22,222
Stock Option (Right to Buy)
[F7]Exercise: $9.45Exp: 2029-05-01→ Common Stock (22,222 underlying) - 46,355
Stock Option (Right to Buy)
[F8]Exercise: $10.05Exp: 2029-09-01→ Common Stock (46,355 underlying) - 36,508
Stock Option (Right to Buy)
[F9]Exercise: $19.65Exp: 2030-05-11→ Common Stock (36,508 underlying) - 6,503
Restricted Stock Unit
[F10][F11]Exercise: $0.00→ Common Stock (6,503 underlying) - 19,508
Performance Stock Unit
[F12][F11]Exercise: $0.00From: 2026-05-11→ Common Stock (19,508 underlying) - 42,344
Stock Option (Right to Buy)
[F13]Exercise: $16.45Exp: 2034-02-23→ Common Stock (42,344 underlying) - 59,382
Restricted Stock Unit
[F11]Exercise: $0.00From: 2026-01-13→ Common Stock (59,382 underlying) - 25,330
Performance Stock Unit
[F14][F11]Exercise: $0.00From: 2027-02-23→ Common Stock (25,330 underlying) - 16,886
Restricted Stock Unit
[F15][F11]Exercise: $0.00→ Common Stock (16,886 underlying) - 107,450
Stock Option (Right to Buy)
[F16][F17]Exercise: $13.05Exp: 2035-02-21→ Common Stock (107,450 underlying) - 63,238
Restricted Stock Unit
[F18][F11]Exercise: $0.00→ Common Stock (63,238 underlying)
Footnotes (18)
- [F1]Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
- [F10]On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F11]Once vested, the shares of common stock are not subject to expiration.
- [F12]On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
- [F13]On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F14]On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- [F15]On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F16]This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
- [F17]On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F18]On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- [F2]Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
- [F3]On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F4]On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F5]On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F6]On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F7]On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F8]On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- [F9]On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
Signature
/s/ Alicia C. Olivo|2026-01-15
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001951869
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 4:22 PM ET
- Size
- 28.7 KB